The Predictive Human Toxicity and ADME/Tox Studies is a conference dedicated to advances in predicting human toxicities and screening earlier in the drug discovery process including topics such as:
- PK/PD
- ADME Optimisation for Drug Design/Discovery
- Biobased Cellular Toxicity Assays
- High Content Screening
- MIP-DILI | IMI
- Metabolomics
- In Vitro QT Prolongation Assays with Cardiomyocytes
- IPS-derived Primary Cultures for Toxicity Assays
- Biomarker Identification with Toxicogenomics
- Genotoxicity
- Pharmacogenomics and Drug Safety
- New Therapeutic Targets in Drug Design/Discovery
- A Novel Human Hepatocyte Assay for Accurate Prediction of Severe DILI Drugs
- Regulatory Issues in ADME
- Translational Investigation of Drug Disposition in Children
The Predictive Human Toxicity and ADME/Tox Studies conference brings together scientific experts, researchers and managers from CRO, Biotech and Pharmaceutical Industries.
